BBusiness Read More RedHill Biopharma Announces Closing of Up To $19.4 Million Private PlacementJune 22, 2026 $6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in…
BBusiness Read More RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational HighlightsApril 27, 2026 2025 was a year of tenacity, strategic transactions and building traction for RedHill Talicia® business transformed: Formation of Talicia…